Honda Begins Joint Research on AI Technologies with the Indian Institutes of Technology in Delhi and Bombay to Further Advance Honda CI (Cooperative Intelligence)
11 Sep
Top Stories

Honda Begins Joint Research on AI Technologies with the Indian Institutes of Technology in Delhi and Bombay to Further Advance Honda CI (Cooperative Intelligence)

Posted by author-avatar
0
Top Stories Tamfitronics TOKYO, Sept 11, 2024 - (JCN Newswire) - Honda(1) today announced that it has begun joint research on AI technologies with the Indian Institutes of Technology (IITs), more specifically, Indian Institute of Technology Delhi (IIT Delhi) and Indian Institute of Technology Bombay (IIT Bombay), to further advance Honda CI (Cooperative Intelligence, CI(2)), original Honda AI that enables mutual understanding between machines and people.The IITs are a home to a large number of excellent researchers and engineers, and through the joint research with those institutes, Honda will strive to advance the underlying technologies of CI, with an eye toward the future applications for technologies that reduce traffic collisions and enable automated driving.Honda has been working on research and development of CI with the aim to realize a society where each and every person...
Continue reading
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies
11 Sep
Top Stories

EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies

Posted by author-avatar
0
Top Stories Tamfitronics HONG KONG, Sept 11, 2024 - (ACN Newswire) - HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases, presents at the 60th European Association for the Study of Diabetes (EASD) Annual Meeting, taking place from September 10-13, 2024 in Madrid, Spain. The presentations include post-hoc analyses of two Phase 2 clinical studies of berberine ursodeoxycholate (HTD1801), a gut-liver anti-inflammatory metabolic modulator, in patients with type 2 diabetes mellitus (T2DM).“These data provide additional insight on the potential benefits of HTD1801, a novel, multifunctional therapy being developed for the treatment of patients with T2DM. The two ongoing Phase 3 studies (NCT06350890, NCT06415773), fully enrolled in 2Q 2024, evaluate the efficacy and safety of HTD1801 in T2DM patients (as monotherapy or...
Continue reading
Fast Debt Recovery Specialist Among First Licensed Under Singapore’s New Debt Collection Rules
11 Sep
Top Stories

Fast Debt Recovery Specialist Among First Licensed Under Singapore’s New Debt Collection Rules

Posted by author-avatar
0
Top Stories Tamfitronics SINGAPORE, Sept 11, 2024 - (ACN Newswire) -Fast Debt Recovery Specialist, Singapore's premier debt collection agency, has achieved a significant milestone by becoming one of the first to receive the newly implemented debt collection licence by the Singapore government. This certification underscores the agency's unwavering commitment to lawful and effective debt collection practices. In line with their business philosophy, "No one deserves to be a victim of broken promises," this licence further solidifies their dedication to ethical and transparent operations.Founded in 2017, Fast Debt Recovery Specialist has rapidly grown to become the preferred collection partner for businesses and individuals seeking assistance with local debt collection. The agency distinguishes itself by blending personalised field visits with cutting-edge technology and a robust benchmarking system, ensuring transparency and accuracy in all operations. Their compliance rate...
Continue reading
Kincora Investor Presentation
11 Sep
Top Stories

Kincora Investor Presentation

Posted by author-avatar
0
Top Stories Tamfitronics Kincora Investor PresentationMelbourne, Australia--(ACN Newswire - September 10, 2024) - Kincora Copper Limited (ASX: KCC) (TSXV: KCC) (KCC, Kincora or the Company). Please find attached for release to the market, Kincora Copper Limited's Investor Presentation - September 2024.https://app.box.com/s/1xwbafyoutfgd7ldw8tn7c57zr1ci8riThis announcement has been authorised for release by the Board of Kincora Copper Limited (ARBN 645 457 763).Executive office400 - 837 West Hastings Street Vancouver, BC V6C 3N6, Canada Tel: 1.604.283.1722 Fax: 1.888.241.5996Subsidiary office AustraliaAustralia View Level 4, 100 Albert RoadSouth Melbourne, Victoria 3205To view the source version of this press release, please visit https://www.newsfilecorp.com/release/222782Topic: Press release summarySource: Kincora Copper Limited Sectors: Metals & Mininghttp://www.acnnewswire.comFrom the Asia Corporate News NetworkCopyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Continue reading
Load more posts
Loading...